Timing of prophylactic hysterectomy-oophorectomy, mastectomy, and microsurgical breast reconstruction in BRCA1 and BRCA2 carriers

Background BRCA (breast cancer susceptibility gene) carriers are at high risk for breast and ovarian malignancies, and often undergo prophylactic total abdominal hysterectomy‐bilateral salpingo‐oophorectomy (TAH‐BSO), bilateral mastectomy, and microsurgical breast reconstruction. Our goal was to det...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Microsurgery 2014-05, Vol.34 (4), p.271-276
Hauptverfasser: Khansa, Ibrahim, Wang, Duane, Coriddi, Michelle, Tiwari, Pankaj
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 276
container_issue 4
container_start_page 271
container_title Microsurgery
container_volume 34
creator Khansa, Ibrahim
Wang, Duane
Coriddi, Michelle
Tiwari, Pankaj
description Background BRCA (breast cancer susceptibility gene) carriers are at high risk for breast and ovarian malignancies, and often undergo prophylactic total abdominal hysterectomy‐bilateral salpingo‐oophorectomy (TAH‐BSO), bilateral mastectomy, and microsurgical breast reconstruction. Our goal was to determine whether abdominal wall complications and flap choice are affected by the order of those procedures. Methods All BRCA carriers who underwent microsurgical breast reconstruction between 2007 and 2012 were studied. Abdominal wall complications and changes in the reconstructive plan were analyzed depending on the order of breast reconstruction and TAH‐BSO. Results 442 patients underwent 612 microsurgical breast reconstructions, 47 of whom were BRCA carriers. TAH‐BSO was not a predictor of requiring mesh for fascial closure (OR 1.1, P = 0.8), or of hernia/bulge (OR = 1.6, P = 0.65). In five patients, a DIEP flap was altered to another flap as a direct result of prior TAH‐BSO. Robotic TAH‐BSO after breast reconstruction took longer to perform than before breast reconstruction (4.48 ± 1.00 hours vs. 3.23 ± 0.70 hours, respectively, P = 0.023), due to abdominal wall tightness. However, none were converted to open. Full‐muscle free TRAM flaps (compared to other flaps) and bilateral reconstructions (compared to unilateral) were the only predictors of mesh (OR = 9.85, P < 0.001 and 4.01, P < 0.001), and hernia/bulge (OR = 6.18, P < 0.001 and 2.13, P = 0.07). The order of TAH‐BSO and breast reconstruction did not affect complications. Conclusions In BRCA carriers, the order of TAH‐BSO and microsurgical breast reconstruction does not affect complication rates. However, prior TAH‐BSO may make DIEP flaps unfeasible, and robotic TAH‐BSO after breast reconstruction takes longer, but can still be performed safely. © 2013 Wiley Periodicals, Inc. Microsurgery 34:271–276, 2014.
doi_str_mv 10.1002/micr.22195
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1513051429</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3265339901</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3605-feaf4c6afca3098a43bbc28672a822738c5a2899315dc0399da9a8a7704768683</originalsourceid><addsrcrecordid>eNpdkU9v1DAQxS0EokvhwgdAlrhwIK3_xLF9LBG0VUuh1aIerVmv07ok8WInghz55nV2lx44-Vnv98aeGYTeUnJECWHHnbfxiDGqxTO0oESrgknBnqMFkVwVlChxgF6l9EAI0Vrql-iAlZRxqssF-rv0ne_vcGjwJobN_dSCHbzF91MaXHR2CN1UhGyE_eUj7iBbew39Gs_PhzTGO2-hxavoso8zHfo0xDFXCz32Pf50U5_QbWBWDFuI0buYXqMXDbTJvdmfh-jHl8_L-qy4_HZ6Xp9cFpZXRBSNg6a0FTQWeG4RSr5aWaYqyUAxlhu1ApjSmlOxtoRrvQYNCqQkpaxUpfgh-rCrm_v8Nbo0mM4n69oWehfGZKignAhaMp3R9_-hD2GMff7dTLFSC0J5pt7tqXHVubXZRN9BnMy_4WaA7oDfvnXTk0-Jmddm5rmZ7drM1_P6ZqtypthlfB7yn6cMxJ-mklwKc3t1aurrM3Fxe_3dLPkjblaaYA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1512495013</pqid></control><display><type>article</type><title>Timing of prophylactic hysterectomy-oophorectomy, mastectomy, and microsurgical breast reconstruction in BRCA1 and BRCA2 carriers</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Khansa, Ibrahim ; Wang, Duane ; Coriddi, Michelle ; Tiwari, Pankaj</creator><creatorcontrib>Khansa, Ibrahim ; Wang, Duane ; Coriddi, Michelle ; Tiwari, Pankaj</creatorcontrib><description>Background BRCA (breast cancer susceptibility gene) carriers are at high risk for breast and ovarian malignancies, and often undergo prophylactic total abdominal hysterectomy‐bilateral salpingo‐oophorectomy (TAH‐BSO), bilateral mastectomy, and microsurgical breast reconstruction. Our goal was to determine whether abdominal wall complications and flap choice are affected by the order of those procedures. Methods All BRCA carriers who underwent microsurgical breast reconstruction between 2007 and 2012 were studied. Abdominal wall complications and changes in the reconstructive plan were analyzed depending on the order of breast reconstruction and TAH‐BSO. Results 442 patients underwent 612 microsurgical breast reconstructions, 47 of whom were BRCA carriers. TAH‐BSO was not a predictor of requiring mesh for fascial closure (OR 1.1, P = 0.8), or of hernia/bulge (OR = 1.6, P = 0.65). In five patients, a DIEP flap was altered to another flap as a direct result of prior TAH‐BSO. Robotic TAH‐BSO after breast reconstruction took longer to perform than before breast reconstruction (4.48 ± 1.00 hours vs. 3.23 ± 0.70 hours, respectively, P = 0.023), due to abdominal wall tightness. However, none were converted to open. Full‐muscle free TRAM flaps (compared to other flaps) and bilateral reconstructions (compared to unilateral) were the only predictors of mesh (OR = 9.85, P &lt; 0.001 and 4.01, P &lt; 0.001), and hernia/bulge (OR = 6.18, P &lt; 0.001 and 2.13, P = 0.07). The order of TAH‐BSO and breast reconstruction did not affect complications. Conclusions In BRCA carriers, the order of TAH‐BSO and microsurgical breast reconstruction does not affect complication rates. However, prior TAH‐BSO may make DIEP flaps unfeasible, and robotic TAH‐BSO after breast reconstruction takes longer, but can still be performed safely. © 2013 Wiley Periodicals, Inc. Microsurgery 34:271–276, 2014.</description><identifier>ISSN: 0738-1085</identifier><identifier>EISSN: 1098-2752</identifier><identifier>DOI: 10.1002/micr.22195</identifier><identifier>PMID: 24123194</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Breast Neoplasms - genetics ; Breast Neoplasms - prevention &amp; control ; Female ; Genes, BRCA1 ; Genes, BRCA2 ; Heterozygote ; Humans ; Hysterectomy ; Mammaplasty - methods ; Mastectomy ; Microsurgery ; Ovarian Neoplasms - genetics ; Ovarian Neoplasms - prevention &amp; control ; Ovariectomy ; Prophylactic Surgical Procedures ; Retrospective Studies ; Time Factors ; Uterine Neoplasms - genetics ; Uterine Neoplasms - prevention &amp; control</subject><ispartof>Microsurgery, 2014-05, Vol.34 (4), p.271-276</ispartof><rights>Copyright © 2013 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3605-feaf4c6afca3098a43bbc28672a822738c5a2899315dc0399da9a8a7704768683</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fmicr.22195$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fmicr.22195$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24123194$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Khansa, Ibrahim</creatorcontrib><creatorcontrib>Wang, Duane</creatorcontrib><creatorcontrib>Coriddi, Michelle</creatorcontrib><creatorcontrib>Tiwari, Pankaj</creatorcontrib><title>Timing of prophylactic hysterectomy-oophorectomy, mastectomy, and microsurgical breast reconstruction in BRCA1 and BRCA2 carriers</title><title>Microsurgery</title><addtitle>Microsurgery</addtitle><description>Background BRCA (breast cancer susceptibility gene) carriers are at high risk for breast and ovarian malignancies, and often undergo prophylactic total abdominal hysterectomy‐bilateral salpingo‐oophorectomy (TAH‐BSO), bilateral mastectomy, and microsurgical breast reconstruction. Our goal was to determine whether abdominal wall complications and flap choice are affected by the order of those procedures. Methods All BRCA carriers who underwent microsurgical breast reconstruction between 2007 and 2012 were studied. Abdominal wall complications and changes in the reconstructive plan were analyzed depending on the order of breast reconstruction and TAH‐BSO. Results 442 patients underwent 612 microsurgical breast reconstructions, 47 of whom were BRCA carriers. TAH‐BSO was not a predictor of requiring mesh for fascial closure (OR 1.1, P = 0.8), or of hernia/bulge (OR = 1.6, P = 0.65). In five patients, a DIEP flap was altered to another flap as a direct result of prior TAH‐BSO. Robotic TAH‐BSO after breast reconstruction took longer to perform than before breast reconstruction (4.48 ± 1.00 hours vs. 3.23 ± 0.70 hours, respectively, P = 0.023), due to abdominal wall tightness. However, none were converted to open. Full‐muscle free TRAM flaps (compared to other flaps) and bilateral reconstructions (compared to unilateral) were the only predictors of mesh (OR = 9.85, P &lt; 0.001 and 4.01, P &lt; 0.001), and hernia/bulge (OR = 6.18, P &lt; 0.001 and 2.13, P = 0.07). The order of TAH‐BSO and breast reconstruction did not affect complications. Conclusions In BRCA carriers, the order of TAH‐BSO and microsurgical breast reconstruction does not affect complication rates. However, prior TAH‐BSO may make DIEP flaps unfeasible, and robotic TAH‐BSO after breast reconstruction takes longer, but can still be performed safely. © 2013 Wiley Periodicals, Inc. Microsurgery 34:271–276, 2014.</description><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - prevention &amp; control</subject><subject>Female</subject><subject>Genes, BRCA1</subject><subject>Genes, BRCA2</subject><subject>Heterozygote</subject><subject>Humans</subject><subject>Hysterectomy</subject><subject>Mammaplasty - methods</subject><subject>Mastectomy</subject><subject>Microsurgery</subject><subject>Ovarian Neoplasms - genetics</subject><subject>Ovarian Neoplasms - prevention &amp; control</subject><subject>Ovariectomy</subject><subject>Prophylactic Surgical Procedures</subject><subject>Retrospective Studies</subject><subject>Time Factors</subject><subject>Uterine Neoplasms - genetics</subject><subject>Uterine Neoplasms - prevention &amp; control</subject><issn>0738-1085</issn><issn>1098-2752</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU9v1DAQxS0EokvhwgdAlrhwIK3_xLF9LBG0VUuh1aIerVmv07ok8WInghz55nV2lx44-Vnv98aeGYTeUnJECWHHnbfxiDGqxTO0oESrgknBnqMFkVwVlChxgF6l9EAI0Vrql-iAlZRxqssF-rv0ne_vcGjwJobN_dSCHbzF91MaXHR2CN1UhGyE_eUj7iBbew39Gs_PhzTGO2-hxavoso8zHfo0xDFXCz32Pf50U5_QbWBWDFuI0buYXqMXDbTJvdmfh-jHl8_L-qy4_HZ6Xp9cFpZXRBSNg6a0FTQWeG4RSr5aWaYqyUAxlhu1ApjSmlOxtoRrvQYNCqQkpaxUpfgh-rCrm_v8Nbo0mM4n69oWehfGZKignAhaMp3R9_-hD2GMff7dTLFSC0J5pt7tqXHVubXZRN9BnMy_4WaA7oDfvnXTk0-Jmddm5rmZ7drM1_P6ZqtypthlfB7yn6cMxJ-mklwKc3t1aurrM3Fxe_3dLPkjblaaYA</recordid><startdate>201405</startdate><enddate>201405</enddate><creator>Khansa, Ibrahim</creator><creator>Wang, Duane</creator><creator>Coriddi, Michelle</creator><creator>Tiwari, Pankaj</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QO</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201405</creationdate><title>Timing of prophylactic hysterectomy-oophorectomy, mastectomy, and microsurgical breast reconstruction in BRCA1 and BRCA2 carriers</title><author>Khansa, Ibrahim ; Wang, Duane ; Coriddi, Michelle ; Tiwari, Pankaj</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3605-feaf4c6afca3098a43bbc28672a822738c5a2899315dc0399da9a8a7704768683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - prevention &amp; control</topic><topic>Female</topic><topic>Genes, BRCA1</topic><topic>Genes, BRCA2</topic><topic>Heterozygote</topic><topic>Humans</topic><topic>Hysterectomy</topic><topic>Mammaplasty - methods</topic><topic>Mastectomy</topic><topic>Microsurgery</topic><topic>Ovarian Neoplasms - genetics</topic><topic>Ovarian Neoplasms - prevention &amp; control</topic><topic>Ovariectomy</topic><topic>Prophylactic Surgical Procedures</topic><topic>Retrospective Studies</topic><topic>Time Factors</topic><topic>Uterine Neoplasms - genetics</topic><topic>Uterine Neoplasms - prevention &amp; control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khansa, Ibrahim</creatorcontrib><creatorcontrib>Wang, Duane</creatorcontrib><creatorcontrib>Coriddi, Michelle</creatorcontrib><creatorcontrib>Tiwari, Pankaj</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Microsurgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khansa, Ibrahim</au><au>Wang, Duane</au><au>Coriddi, Michelle</au><au>Tiwari, Pankaj</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Timing of prophylactic hysterectomy-oophorectomy, mastectomy, and microsurgical breast reconstruction in BRCA1 and BRCA2 carriers</atitle><jtitle>Microsurgery</jtitle><addtitle>Microsurgery</addtitle><date>2014-05</date><risdate>2014</risdate><volume>34</volume><issue>4</issue><spage>271</spage><epage>276</epage><pages>271-276</pages><issn>0738-1085</issn><eissn>1098-2752</eissn><abstract>Background BRCA (breast cancer susceptibility gene) carriers are at high risk for breast and ovarian malignancies, and often undergo prophylactic total abdominal hysterectomy‐bilateral salpingo‐oophorectomy (TAH‐BSO), bilateral mastectomy, and microsurgical breast reconstruction. Our goal was to determine whether abdominal wall complications and flap choice are affected by the order of those procedures. Methods All BRCA carriers who underwent microsurgical breast reconstruction between 2007 and 2012 were studied. Abdominal wall complications and changes in the reconstructive plan were analyzed depending on the order of breast reconstruction and TAH‐BSO. Results 442 patients underwent 612 microsurgical breast reconstructions, 47 of whom were BRCA carriers. TAH‐BSO was not a predictor of requiring mesh for fascial closure (OR 1.1, P = 0.8), or of hernia/bulge (OR = 1.6, P = 0.65). In five patients, a DIEP flap was altered to another flap as a direct result of prior TAH‐BSO. Robotic TAH‐BSO after breast reconstruction took longer to perform than before breast reconstruction (4.48 ± 1.00 hours vs. 3.23 ± 0.70 hours, respectively, P = 0.023), due to abdominal wall tightness. However, none were converted to open. Full‐muscle free TRAM flaps (compared to other flaps) and bilateral reconstructions (compared to unilateral) were the only predictors of mesh (OR = 9.85, P &lt; 0.001 and 4.01, P &lt; 0.001), and hernia/bulge (OR = 6.18, P &lt; 0.001 and 2.13, P = 0.07). The order of TAH‐BSO and breast reconstruction did not affect complications. Conclusions In BRCA carriers, the order of TAH‐BSO and microsurgical breast reconstruction does not affect complication rates. However, prior TAH‐BSO may make DIEP flaps unfeasible, and robotic TAH‐BSO after breast reconstruction takes longer, but can still be performed safely. © 2013 Wiley Periodicals, Inc. Microsurgery 34:271–276, 2014.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>24123194</pmid><doi>10.1002/micr.22195</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0738-1085
ispartof Microsurgery, 2014-05, Vol.34 (4), p.271-276
issn 0738-1085
1098-2752
language eng
recordid cdi_proquest_miscellaneous_1513051429
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Breast Neoplasms - genetics
Breast Neoplasms - prevention & control
Female
Genes, BRCA1
Genes, BRCA2
Heterozygote
Humans
Hysterectomy
Mammaplasty - methods
Mastectomy
Microsurgery
Ovarian Neoplasms - genetics
Ovarian Neoplasms - prevention & control
Ovariectomy
Prophylactic Surgical Procedures
Retrospective Studies
Time Factors
Uterine Neoplasms - genetics
Uterine Neoplasms - prevention & control
title Timing of prophylactic hysterectomy-oophorectomy, mastectomy, and microsurgical breast reconstruction in BRCA1 and BRCA2 carriers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T09%3A38%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Timing%20of%20prophylactic%20hysterectomy-oophorectomy,%20mastectomy,%20and%20microsurgical%20breast%20reconstruction%20in%20BRCA1%20and%20BRCA2%20carriers&rft.jtitle=Microsurgery&rft.au=Khansa,%20Ibrahim&rft.date=2014-05&rft.volume=34&rft.issue=4&rft.spage=271&rft.epage=276&rft.pages=271-276&rft.issn=0738-1085&rft.eissn=1098-2752&rft_id=info:doi/10.1002/micr.22195&rft_dat=%3Cproquest_pubme%3E3265339901%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1512495013&rft_id=info:pmid/24123194&rfr_iscdi=true